Based on the analysis of UnitedHealth Group's profitability, liquidity, and operating efficiency, UnitedHealth Group Incorporated is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. As of now, UnitedHealth Group's Property Plant And Equipment Net is increasing as compared to previous years. The UnitedHealth Group's current Net Debt is estimated to increase to about 39 B, while Other Current Assets are projected to decrease to under 6.2 B. Key indicators impacting UnitedHealth Group's financial strength include:
The essential information of the day-to-day investment outlook for UnitedHealth Group includes many different criteria found on its balance sheet. An individual investor should monitor UnitedHealth Group's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in UnitedHealth Group.
Cash And Equivalents
17.36 Billion
UnitedHealth
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Dividends Paid
Stock Based Compensation
Change To Inventory
Change To Liabilities
Other Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Exchange Rate Changes
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Short Long Term Debt Total
Intangible Assets
Other Current Liab
Short Term Debt
Accounts Payable
Short Term Investments
Accumulated Other Comprehensive Income
Common Stock
Good Will
Common Stock Total Equity
Property Plant And Equipment Gross
Other Liab
Other Assets
Long Term Debt
Property Plant Equipment
Inventory
Current Deferred Revenue
Net Tangible Assets
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Long Term Debt Total
Deferred Long Term Liab
Long Term Investments
Non Current Liabilities Other
Warrants
Capital Surpluse
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Interest Expense
Selling General Administrative
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Minority Interest
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past UnitedHealth Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of UnitedHealth Group's financial statements are interrelated, with each one affecting the others. For example, an increase in UnitedHealth Group's assets may result in an increase in income on the income statement.
UnitedHealth Group competes with Cigna Corp, Humana, Elevance Health, Centene Corp, and Molina Healthcare. UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people.
Comparative valuation techniques use various fundamental indicators to help in determining UnitedHealth Group's current stock value. Our valuation model uses many indicators to compare UnitedHealth Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UnitedHealth Group competition to find correlations between indicators driving UnitedHealth Group's intrinsic value. More Info.
UnitedHealth Group Incorporated is rated third in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UnitedHealth Group Incorporated is roughly 2.20 . As of now, UnitedHealth Group's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UnitedHealth Group's earnings, one of the primary drivers of an investment's value.
UnitedHealth Group Systematic Risk
UnitedHealth Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. UnitedHealth Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on UnitedHealth Group correlated with the market. If Beta is less than 0 UnitedHealth Group generally moves in the opposite direction as compared to the market. If UnitedHealth Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one UnitedHealth Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of UnitedHealth Group is generally in the same direction as the market. If Beta > 1 UnitedHealth Group moves generally in the same direction as, but more than the movement of the benchmark.
UnitedHealth Group Thematic Clasifications
UnitedHealth Group Incorporated is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in UnitedHealth Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various UnitedHealth Group's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of UnitedHealth Group growth as a starting point in their analysis.
UnitedHealth Group November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of UnitedHealth Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UnitedHealth Group Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of UnitedHealth Group Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing UnitedHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UnitedHealth Group's daily price indicators and compare them against related drivers.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.